IONIS PHARMACEUTICALS INC's ticker is and the CUSIP is 462222AB6. A total of 16 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,621,783 | +2.3% | 2,756,000 | 0.0% | 2.46% | +6.4% |
| Q2 2023 | $2,563,224 | +1.0% | 2,756,000 | 0.0% | 2.31% | -4.0% |
| Q1 2023 | $2,537,097 | +122.4% | 2,756,000 | +119.4% | 2.41% | +89.1% |
| Q4 2022 | $1,140,574 | +0.4% | 1,256,000 | 0.0% | 1.27% | -14.4% |
| Q3 2022 | $1,136,000 | +3.0% | 1,256,000 | 0.0% | 1.49% | 0.0% |
| Q2 2022 | $1,103,000 | -2.0% | 1,256,000 | 0.0% | 1.49% | +13.9% |
| Q1 2022 | $1,126,000 | +47.2% | 1,256,000 | +146629.0% | 1.31% | +59.3% |
| Q4 2021 | $765,000 | -2.9% | 856 | 0.0% | 0.82% | -34.2% |
| Q3 2021 | $788,000 | -0.3% | 856 | 0.0% | 1.25% | +26.2% |
| Q2 2021 | $790,000 | +48.8% | 856 | -99.8% | 0.99% | +64.5% |
| Q1 2021 | $531,000 | +46.3% | 556,000 | +56.2% | 0.60% | +86.9% |
| Q4 2020 | $363,000 | – | 356,000 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opti Capital Management, LP | 36,587,000 | $34,026,000 | 3.65% |
| DeepCurrents Investment Group LLC | 77,144,000 | $71,504,000 | 2.14% |
| STEELHEAD PARTNERS LLC | 28,000,000 | $26,028,000 | 1.72% |
| Context Capital Management, LLC | 13,000 | $12,147,000 | 1.12% |
| CAMDEN ASSET MANAGEMENT L P /CA | 26,324,000 | $24,465,000 | 1.02% |
| Penn Mutual Asset Management, LLC | 856 | $790,000 | 0.99% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 41,774,000 | $38,742,000 | 0.84% |
| PFM Health Sciences, LP | 23,000,000 | $21,372,000 | 0.67% |
| AQR Arbitrage LLC | 19,050,000 | $17,800,000 | 0.50% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 19,910,000 | $18,377,000 | 0.36% |